폐활량계 시장 규모, 점유율, 예측 및 동향 분석 : 제품별, 기술별, 용도별, 최종 사용자별 - 세계 예측(-2031년)

Spirometer Market Size, Share, Forecast, & Trends Analysis by Product (Spirometer ) Technology (Volume, Peak Flow) Application (COPD, Asthma, Cystic fibrosis) End User - Global Forecast to 2031

US $ 4,175 ￦ 6,162,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회만 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,875 ￦ 8,672,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,875 ￦ 11,624,000

PDF (Global Site License)

PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 폐활량계 시장은 2024-2031년간 9.2%의 연평균 복합 성장률(CAGR)로 2031년까지 18억 달러에 달할 것으로 예상됩니다.

이 보고서는 광범위한 2차 및 1차 연구와 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 억제요인, 도전 과제 및 기회 분석으로 구성되어 있습니다. 호흡기 질환의 유병률 증가, 호흡기 질환의 기술 발전, 호흡기 질환에 대한 인식 제고 프로그램 증가, 재택치료에 대한 선호도 증가 등이 호흡기 측정기 시장의 성장을 견인하고 있습니다. 그러나 폐활량계의 높은 비용과 숙련된 전문가의 부족은 이 시장의 성장을 저해하는 요인입니다.

또한, 폐활량계 개발을 위한 시장 기업들간의 제휴 및 협력 관계, 신흥국 수요 증가는 이 시장에서 사업을 운영하는 기업들에게 성장 기회를 제공할 것으로 예상됩니다. 그러나 대체 기술의 가용성은 시장 성장에 큰 도전이 되고 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 인사이트

• 개요
• 성장 촉진요인
• 성장 억제요인
• 기회
• 과제
• 동향
• 요인 분석
• 규제 분석
• 가격 분석
• 사례 연구
• Porter의 Five Forces 분석

제5장 폐활량계 시장 : 제품별 평가

• 개요
• 디바이스
  • 디바이스 유형
    • Incentive Spirometers
    • Professional Spirometers
    • Digital Peak Flow Meters
    • Smart Digital Spirometers
    • 기타 기기
  • 휴대성
    • 탁상형/고정형 폐활량계
    • 핸드헬드 폐활량계
  • 접속 유형
    • 무선
    • USB 폐활량계
• 소모품 및 액세서리
• 소프트웨어

제6장 폐활량계 시장 : 기술별 평가

• 개요
• 피크 플로우 측정
• 용적 측정

제7장 폐활량계 시장 : 용도별 평가

• 개요
• 만성 폐쇄성 폐질환(COPD)
• 천식
• 낭포성 섬유증
• 폐 섬유증
• 기타 용도

제8장 폐활량계 시장 : 최종사용자별 평가

• 개요
• 병원 및 진료소
• 재택치료
• 외래 케어 센터

제9장 폐활량계 시장 : 지역별 평가

• 개요
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 스위스
  • 네덜란드
  • 기타 유럽
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 싱가포르
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 아랍에미리트(UAE)
  • 사우디아라비아
  • 남아프리카공화국
  • 기타 중동 및 아프리카

제10장 경쟁 분석

• 개요
• 주요 성장 전략
• 경쟁 벤치마킹
• 경쟁 대시보드
  • 업계 리더
  • 시장 차별화 요인
  • 선행 기업
• 신규 기업
• 주요 기업의 시장 점유율 분석/시장 순위(2023년)

제11장 기업 개요(사업 개요, 재무 개요, 제품 포트폴리오, 전략적 전개, SWOT 분석*)

• Hill-Rom Holdings, Inc.(a subsidiary of Baxter International Inc.)
• Schiller Americas Inc.
• Vyaire Medical, Inc.
• Koninklijke Philips N.V.
• KoKo, LLC
• Midmark Corporation
• Geratherm Medical AG
• CHEST M.I., Inc.
• Fukuda Sangyo Co., Ltd.
• ndd Medical Technologies
• MGC Diagnostics Corporation
• COSMED srl
• SIBEL, SAU

(주 : 주요 5개사의 SWOT 분석을 게재)

제12장 부록

LSH

영문 목차

영문목차

Spirometers Market Size, Share, Forecast, & Trends Analysis by Product (Spirometer [Incentive, Professional, Wireless, Handheld, Stationary, USB]) Technology (Volume, Peak Flow) Application (COPD, Asthma, Cystic fibrosis) End User-Global Forecast to 2031

The global spirometers market is projected to reach $1.80 billion by 2031 at a CAGR of 9.2% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the spirometers market is driven by the rising incidence of respiratory diseases, technological advancements in spirometers, increasing awareness programs regarding respiratory diseases, and the growing preference for home healthcare. However, the high cost of spirometers and a shortage of skilled professionals restrain the growth of this market.

Furthermore, partnerships & collaborations between market players aimed at advancing spirometers and the rising demand from emerging economies are expected to generate growth opportunities for the players operating in this market. However, the availability of alternative technologies poses a major challenge to market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global spirometers market are Hill-Rom Holdings, Inc. (U.S.) (a subsidiary of Baxter International Inc. (U.S.)), Schiller Americas Inc. (U.S.), Vyaire Medical, Inc. (U.S.), Koninklijke Philips N.V.(Netherlands), KoKo, LLC (U.S.), Midmark Corporation (U.S.), Geratherm Medical AG (Germany), CHEST M.I., Inc. (Japan), Fukuda Sangyo Co., Ltd. (Japan), ndd Medical Technologies (U.S.), MGC Diagnostics Corporation (U.S.), COSMED srl (Italy), and SIBEL, SAU (Spain).

Among all the products studied in this report, the devices segment is expected to account for the largest share of over 65.2% of the spirometers market. This segment's large market share can be attributed to the increasing approvals of spirometer devices, technological advancements in these devices, and their widespread adoption for monitoring disease progression.

Among all the technologies studied in this report, in 2024, the peak flow measurement segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the ease of use, portability, and cost-effectiveness of peak flow measurement spirometers. These devices are simpler to operate and require minimal setup compared to volume-based devices.

Among all the applications studied in this report, in 2024, the Chronic Obstructive Pulmonary Disease (COPD) segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the high burden of chronic obstructive pulmonary disease (COPD). For instance, according to the National Institutes of Health (NIH), in 2022, 300 million people worldwide were diagnosed with COPD.

Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the rising cases of respiratory conditions such as asthma, COPD, and pulmonary fibrosis, leading to a significant number of patient visits to hospitals and clinics. For instance, according to the Australian Bureau of Statistics, in 2022, 2.8 million individuals were reported to have asthma in Australia.

An in-depth analysis of the geographical scenario of the global spirometers market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 41.6% of the spirometers market. In the region in 2024, the U.S. is expected to account for the largest share of the spirometers market in North America. The large share of the regional market is attributed to the increasing incidence of respiratory diseases leading to higher hospital admissions, the well-established healthcare sector, and the presence of prominent spirometer companies, such as Hill-Rom Holdings, Inc. (U.S.) and Midmark Corporation (U.S.), in this region.

Scope of the Report:

Spirometers Market Assessment-by Product

• Devices
  • Type
• Incentive Spirometers
• Professional Spirometers
• Digital Peak Flow Meters
• Smart Digital Spirometers
• Other Spirometers
  • Portability
• Table-top/Stationary Spirometers
• Handheld Spirometers
  • Connectivity
• Wireless Spirometers
• USB Spirometers
• Consumables & Accessories
• Software

Note: Other Spirometers include windmill-type spirometers and pneumotachometers.

Spirometers Market Assessment-by Technology

• Volume Measurement
• Peak Flow Measurement

Spirometers Market Assessment-by Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Cystic fibrosis
• Pulmonary fibrosis
• Other Applications Chronic Pain

Note: Other Applications include bronchiectasis, lung cancer, emphysema, and chronic bronchitis.

Spirometers Market Assessment-by End User

• Hospitals & Clinics
• Home Care Settings
• Ambulatory Care Centers

Spirometers Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Switzerland
  • Netherlands
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Rising Incidence of Respiratory Diseases
  • 4.2.2. Technological Advancements in Spirometers
  • 4.2.3. Increasing Awareness Programs Regarding Respiratory Diseases
  • 4.2.4. Growing Preference for Home Healthcare
• 4.3. Restraints
  • 4.3.1. High Cost of Spirometers
  • 4.3.2. Shortage of Skilled Professionals
• 4.4. Opportunities
  • 4.4.1. Emerging Economies
  • 4.4.2. Partnerships & Collaborations Between Market Players Aimed at Advancing Spirometers
• 4.5. Challenges
  • 4.5.1. Availability of Alternative Technologies
• 4.6. Trends
  • 4.6.1. Emergence of Wearable Spirometer Devices
  • 4.6.2. Integration of Telehealth and Remote Monitoring With Spirometry
• 4.7. Factor Analysis
• 4.8. Regulatory Analysis
• 4.9. Pricing Analysis
• 4.10. Case Studies
• 4.11. Porter's Five Forces Analysis

5. Spirometer Market Assessment-by Product

• 5.1. Overview
• 5.2. Devices
  • 5.2.1. Device Type
    • 5.2.1.1. Incentive Spirometers
    • 5.2.1.2. Professional Spirometers
    • 5.2.1.3. Digital Peak Flow Meters
    • 5.2.1.4. Smart Digital Spirometers
    • 5.2.1.5. Other Devices
  • 5.2.2. Portability
    • 5.2.2.1. Table-Top/Stationary Spirometers
    • 5.2.2.2. Hand-held Spirometers
  • 5.2.3. Connectivity Type
    • 5.2.3.1. Wireless Spirometers
    • 5.2.3.2. USB Spirometers
• 5.3. Consumables & Accessories
• 5.4. Software

6. Spirometer Market Assessment-by Technology

• 6.1. Overview
• 6.2. Peak Flow Measurement
• 6.3. Volume Measurement

7. Spirometer Market Assessment-by Application

• 7.1. Overview
• 7.2. Chronic Obstructive Pulmonary Disease (COPD)
• 7.3. Asthma
• 7.4. Cystic Fibrosis
• 7.5. Pulmonary Fibrosis
• 7.6. Other Applications

8. Spirometer Market Assessment-by End User

• 8.1. Overview
• 8.2. Hospitals & Clinics
• 8.3. Home Care Settings
• 8.4. Ambulatory Care Centers

9. Spirometer Market Assessment-by Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Switzerland
  • 9.3.7. Netherlands
  • 9.3.8. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. Japan
  • 9.4.2. China
  • 9.4.3. India
  • 9.4.4. Australia
  • 9.4.5. South Korea
  • 9.4.6. Singapore
  • 9.4.7. Rest of Asia-Pacific
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Argentina
  • 9.5.4. Rest of Latin America
• 9.6. Middle East & Africa
  • 9.6.1. UAE
  • 9.6.2. Saudi Arabia
  • 9.6.3. South Africa
  • 9.6.4. Rest of Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Market Differentiators
  • 10.4.3. Vanguards
• 10.4. Emerging Companies
• 10.5. Market Share Analysis/Market Rankings of Key Players (2023)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

• 11.1. Hill-Rom Holdings, Inc. (a subsidiary of Baxter International Inc.)
• 11.2. Schiller Americas Inc.
• 11.3. Vyaire Medical, Inc.
• 11.4. Koninklijke Philips N.V.
• 11.5. KoKo, LLC
• 11.6. Midmark Corporation
• 11.7. Geratherm Medical AG
• 11.8. CHEST M.I., Inc.
• 11.9. Fukuda Sangyo Co., Ltd.
• 11.10. ndd Medical Technologies
• 11.11. MGC Diagnostics Corporation
• 11.12. COSMED srl
• 11.13 SIBEL, SAU

(Note: SWOT analyses of the top 5 companies will be provided.)

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports

관련자료